What's the price gap between tigecycline generics and brand?

Tigecycline (brand Tygacil vs. generics)
The price difference between the Pfizer‑branded Tygacil and the first‑entry generic versions is generally a 30‑50 % discount, though the exact numbers can vary by pharmacy, payer contract, and region. Below is a snapshot of typical U.S. wholesale acquisition costs (WAC) and average retail prices for a 50 mg vial (the standard dose used in most infections) as of mid‑2024:

Key Take‑aways

1. Generics are noticeably cheaper – most pharmacies list generic tigecycline at about 35 % lower than the branded version.
2. The “price gap” is largely a function of the manufacturer’s cost structure. The brand has invested heavily in R&D and marketing; the generic producers rely on lower manufacturing overhead and no brand‑name marketing.
3. Insurance coverage can blur the gap. If your insurance has a formulary that prefers the generic, you’ll see a smaller out‑of‑pocket difference; if the formulary keeps the brand as the preferred option, the gap may be larger.
4. Availability matters. In some regions or hospital formularies, only the brand is stocked, so the price advantage of generics isn’t realized.

Quick reference

• Brand (Tygacil): ≈ $200–$250 per 50 mg vial (retail).
• Generic: ≈ $120–$160 per 50 mg vial (retail).
• Price gap: ≈ $80–$90 (≈ 35 % difference).

These figures are approximate and based on publicly available WAC and pharmacy pricing data for 2024. Always check with your pharmacy or insurer for the exact cost you’ll pay.